Anti-CCR5 antibody [T21/8]
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(5 Publications)
Mouse Recombinant Monoclonal CCR5 antibody. Suitable for Flow Cyt, I-ELISA and reacts with Human samples. Cited in 5 publications.
View Alternative Names
CD195, CMKBR5, CCR5, C-C chemokine receptor type 5, C-C CKR-5, CC-CKR-5, CCR-5, CHEMR13, HIV-1 fusion coreceptor
- Flow Cyt
Lab
Flow Cytometry - Anti-CCR5 antibody [T21/8] (AB110103)
Flow cytometric analysis of Human peripheral blood mononuclear cells (PBMC) cells labelling CCR5 with ab110103 at 1/100 dilution (0.1&micor;g)/Right followed by a secondary antibody Goat anti-Mouse IgG (Alexa Fluor® 488, ab150113) used at a 1/2000 dilution compared with isotype control Mouse monoclonal IgG / Left.
Cells were stained with mouse IgG or ab110103. Then stained with anti-CD3 conjugated to APC (the conjugation was performed by using ab240074 and APC Conjugation Kit - Lightning-Link® (ab201807)).
Gated on viable lymphocytes.
- I-ELISA
Lab
Indirect ELISA - Anti-CCR5 antibody [T21/8] (AB110103)
Indirect ELISA analysis of ab110103 used at a range 0-2000 ng/ml. Antigen used was Human CCR5 at 1000 ng/ml. The Secondary antibody used was Alkaline Phosphatase-conjugated AffiniPure Goat Anti-Mouse IgG (H+L) at 1/1000 dilution dilution.
Related conjugates and formulations (4)
-
660 APC
APC Anti-CCR5 antibody [T21/8]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-CCR5 antibody [T21/8]
-
387 mFluor™ UV375
mFluor™ UV375 Anti-CD195 antibody [T21/8]
-
mFluor™ Violet 450 Anti-CD195 antibody [T21/8]
Reactivity data
Product details
The production method has been switched from hybridoma to recombinant on 06th June 2025.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CCR5 acts as a receptor for various chemokines specifically CCL3 CCL4 and CCL5 which are involved in leukocyte trafficking and immune response modulation. It plays an important role in the migration of immune cells to sites of inflammation or injury. This protein does not function in isolation; it sometimes forms part of larger complexes with other cell surface proteins to mediate responses to external signals. For example anti-CCR5 antibodies like 12D1 can modulate its activity and influence immune cell behavior.
Pathways
CCR5 is intricately involved in chemokine signaling pathways and inflammatory response pathways. Through these pathways it interacts with proteins such as CXCR4 and CCR1. CCR5 and CXCR4 another chemokine receptor are well-documented for their role in HIV entry into host cells. These pathways are critical for orchestrating immune cell movement and activating signaling cascades that promote immune defense mechanisms.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10:e2302527 PubMed37867250
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal for immunotherapy of cancer 11: PubMed37185233
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 12:551839 PubMed33953665
2021
Applications
Unspecified application
Species
Unspecified reactive species
Experimental dermatology 28:816-821 PubMed31006151
2019
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 13:3379-3386 PubMed28521443
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com